Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Rachel Dobkin

Major bank CEO says company spends $250 million a year on GLP-1 drugs for its employees

Bank of America’s chief executive has said the company spends $250 million a year on GLP-1 drugs for its employees as the weight-loss medications surge in popularity.

U.S. adults currently taking a GLP-1 medication for weight loss, such as Ozempic or Wegovy, increased to 11 percent this year, up from 3 percent in 2024, according to a Gallup poll released last month.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.